Last reviewed · How we verify

NCT03176641

Platelet-rich Plasma for Meniscus Repair

Completed NA Last updated 26 December 2018
What this trial tests

NA trial testing platelet-rich plasma in Platelet-Rich Plasma in 60 participants. Completed in 21 November 2018.

Timeline
24 August 2016
Primary endpoint
8 May 2018
21 November 2018

Quick facts

Lead sponsorPei-Yuan Lee, MD
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date24 August 2016
Primary completion8 May 2018
Estimated completion21 November 2018
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Pei-Yuan Lee, MD

Who can join

Adults 20 to 60, any sex, with Platelet-Rich Plasma or Knee Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effect of platelet-rich plasma (PRP) on meniscus injury by comparing the imaging and clinical outcomes between patients receiving PRP with meniscus repair surgery and those receiving meniscus repair surgery only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of platelet-rich plasma

Trials testing the same drug.

Other recruiting trials for Platelet-Rich Plasma

Currently open trials in the same condition.

Other Pei-Yuan Lee, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03176641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing